Sydney Halleman / healthcaredive - The ruling maintains access to mifepristone while litigation continues. The drug can still be prescribed at pharmacies or by mail without requiring in-person visits.
AI Summary: The Supreme Court intervened to maintain access to mifepristone, temporarily restoring telehealth prescribing and preserving mail distribution while litigation proceeds. The decision keeps the pill available nationwide, blocking lower-court restrictions that would have sharply limited remote access and complicated routine clinical care for patients and providers.
Abortion‑pill bans won’t stop telehealth access, providers say / 14 days
Appeals court curbs mail and telehealth access to mifepristone nationwide / 2 months
Telehealth abortion pills rise as teens drive online demand / 3 months
FDA to Remove Black Box Warnings from Menopausal Hormone Therapies / 7 months
Telehealth 'Done' founder jailed six years for Adderall fraud / 7 hrs
FDA updates mifepristone safety review, but pharmacies remain reluctant / 2 months
FDA clears first new sunscreen ingredient in two decades / 28 days
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.